ReviewInvestigational new drugs2018

Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.

Shoichi Deguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.